News | March 08, 2024
Remedium Lifecare to acquire manufacturing facility in Hyderabad
The plan is to set up an ultramodern Solvent Recovery Plant for third party purposes
The plan is to set up an ultramodern Solvent Recovery Plant for third party purposes
Nectar Lifesciences has clarified that the company has no relation/connection/ association or link of any nature with the Nectar Herbs and Drugs
The facility will manufacture Specialty and Fine Chemicals tailored to various applications across industries such as Polymer and Water Treatment facilities
With this, the total number of Patents granted to company for its innovative processes and technology stands at 9
BHL will undertake the development and supply of these molecules
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
The company is strongly committed to enhancing customer satisfaction and catering to the discerning needs of renowned pharmaceutical companies
Subscribe To Our Newsletter & Stay Updated
